Business Context and Reporting Period
This Form 8-K was filed by Exterran Holdings, Inc. (note: the metadata references Archrock, Inc., but the filing text identifies Exterran Holdings, Inc.) on February 22, 2012. The report details the entry into a Material Definitive Agreement, specifically a Contribution, Conveyance and Assumption Agreement, involving Exterran and its subsidiaries, including Exterran Partners, L.P. (the Partnership).
Key Financial Metrics and Transaction Details
- Debt Assumption: EXLP Operating will assume and repay $105.4 million of Exterran's debt.
- Equity Issuance: The Partnership will issue 1,899,453 common units representing limited partner interests to MLP LP LLC or its affiliates (or cash equivalent).
- Cash Consideration: If elected, the Partnership will pay Exterran $33.5 million in cash for the acquisition of Processing Assets.
- Asset Transfer: The transaction involves the conveyance of compression services contracts, compression equipment, and potentially a natural gas processing plant with a capacity of 10 million cubic feet per day.
- Ownership Interest: As of the filing date, Exterran holds an indirect 33% limited partner interest and an approximate 2% general partner interest in the Partnership.
Material Changes and Agreements
The filing outlines a significant restructuring of assets and liabilities between Exterran and its affiliated Partnership. Key changes include:
- Cost Cap Increase: An amendment to the Omnibus Agreement increases the quarterly cap on selling, general, and administrative (SG&A) costs allocated to the Partnership from $9.0 million to $10.5 million.
- Term Extension: The term for caps on reimbursement obligations for SG&A and operating costs is extended by one year, terminating on December 31, 2013.
- Exclusion: Operations of the natural gas processing plant will not be subject to the operating cost cap.
Outlook, Risks, and Contingencies
Closing Conditions: The transaction is expected to close in March 2012, subject to standard conditions including the expiration of the Hart-Scott-Rodino Antitrust Improvements Act waiting period and the execution of the Omnibus Agreement amendment.
Risks: The filing includes forward-looking statements regarding the ability to complete the transaction and timing. Risks include regulatory review outcomes and the failure to satisfy closing conditions. Actual results may differ materially from expectations due to factors outside the company's control.
Investor Verification Checklist
- Verify the final closing date of the transaction in March 2012.
- Confirm whether the conflicts committee elected to purchase the Processing Assets for the $33.5 million cash payment.
- Review the full text of the Contribution Agreement (Exhibit 2.1) for specific asset details and covenants.
- Monitor the impact of the increased SG&A cost cap on future quarterly financial statements.
- Check for any regulatory approvals or delays related to the Hart-Scott-Rodino Act.